Mild Vascular dementia
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01043 | Memantine | An NMDA receptor antagonist used to treat moderate to severe dementia in Alzheimer's. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01043 | Memantine | Cytochrome P450 2B6 | enzyme |
| DB01043 | Memantine | 溶质载体家庭22我mber 2 | transporter |
| DB01043 | Memantine | 5-hydroxytryptamine receptor 3A | target |
| DB01043 | Memantine | Alpha-7 nicotinic cholinergic receptor subunit | target |
| DB01043 | Memantine | Cytochrome P450 2A6 | enzyme |
| DB01043 | Memantine | Cytochrome P450 2C19 | enzyme |
| DB01043 | Memantine | Dopamine D2 receptor | target |
| DB01043 | Memantine | Glutamate receptor ionotropic, NMDA 1 | target |
| DB01043 | Memantine | Sodium/hydrogen exchanger 1 | transporter |
| DB01043 | Memantine | 溶质载体家庭22我mber 4 | transporter |
| DB01043 | Memantine | Multidrug and toxin extrusion protein 1 | transporter |
| DB01043 | Memantine | Glutamate (NMDA) receptor | target |
| DB01043 | Memantine | GABA(A) Receptor | target |
| DB01043 | Memantine | Glycine receptors | target |
| Drug | Drug Name | Phase | Status | Count |
|---|